EGFR

Clinical trials for EGFR explained in plain language.

Never miss a new study

Get alerted when new EGFR trials appear

Sign up with your email to follow new studies for EGFR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 4

Could removing the main tumor boost targeted therapy in advanced lung cancer?

Disease control Not yet recruiting

This study looks at whether surgically removing the primary lung tumor before starting the targeted drug osimertinib can help people with advanced EGFR-mutant non-small cell lung cancer live longer without the disease getting worse. About 118 adults with stage III-IV cancer who h…

Matched conditions: EGFR

Phase: PHASE2 • Sponsor: Jianxing He • Aim: Disease control

Last updated May 17, 2026 07:38 UTC

EGFR

Get alerted when new EGFR trials appear

Could removing the main tumor boost targeted therapy in advanced lung cancer?